LUNG — Pulmonx Corp

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1127537 ·
Last close
$2.73
Market Cap
$119.11M
52W High
$3.25
52W Low
$1.13
ADV30
994,967
Next earnings
2026-10-27

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 22,756,000 17,742,000 -9,057,000 -10,080,000 114,732,000 55,843,000 75,536,000
Mar 2026 20,586,000 16,044,000 -12,956,000 -13,654,000 119,966,000 61,572,000 74,205,000
Dec 2025 22,598,000 17,541,000 -9,903,000 -10,425,000 129,291,000 69,751,000 75,175,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-25,578,000
Investing CF
$-31,000
Financing CF
$1,729,000
CapEx
$-31,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.01
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-553,686,000
Inventory
$15,436,000
Receivables
$12,526,000
ST Investments
$0
EBIT TTM
$-37,736,000
Pretax Income TTM
$-41,934,000
Interest Exp TTM
$4,198,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$88,775,000
EBITDA
$-38,409,000
Free Cash Flow
$-11,744,750
Enterprise Value
$114,188,896
Total Cash
$52,690,000
Total Debt
$56,346,000
Shares Out
43,550,665
Trailing EPS
$-1.01
Book Value
$0.79
ROE
-90.3%
ROA
-19.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 90,497,000 -53,663,000 -54,003,000 129,291,000 75,175,000 54,116,000 -32,376,000
Dec 2024 83,789,000 -57,704,000 -56,394,000 162,850,000 77,041,000 85,809,000 -31,537,000
Dec 2023 68,675,000 -61,935,000 -60,843,000 177,781,000 59,466,000 118,315,000 -37,610,000
Dec 2022 53,662,000 -58,637,000 -58,923,000 193,676,000 39,669,000 154,007,000 -45,083,000

TTM Snapshot

Revenues TTM
$87,442,000
NetIncome TTM
$-48,116,000
OpCashFlow TTM
—
Assets (Latest)
$114,732,000
Forward EPS
$-0.92

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $2.69 · call volume: 43 · put volume: 76
Expected Move to 2027-02-19: ±$1.02 (38.10%) — implied range $1.67 – $3.72 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
APYX Apyx Medical Corp $107.63M $2.56 —
PYPD PolyPid Ltd. $132.84M $6.54 —
FOCL EDAP TMS SA $134.10M $2.84 —
TLSI TriSalus Life Sciences, Inc. $141.60M $2.30 —
STIM Neuronetics, Inc. $99.49M $1.28 —

News headlines (Yahoo Finance, 1h cache)

Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-18 21:05 · Yahoo
Pulmonx Announces Publication of CONVERT Trial Results for AeriSeal® System
2026-11-17 12:10 · Yahoo
Pulmonx: 3 Key Takeaways for Long-Term Investors
2026-11-08 23:35 · Yahoo
All You Need to Know About Pulmonx (LUNG) Rating Upgrade to Buy
2026-10-30 15:00 · Yahoo
Pulmonx to Participate in Upcoming Investor Conferences
2026-10-28 20:05 · Yahoo
Pulmonx (LUNG) Q3 2026 Earnings Call Transcript
2026-10-27 23:43 · Yahoo
What Pulmonx (LUNG) Said on Its Q3 Earnings Call
2026-10-27 23:04 · Yahoo
Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates
2026-10-27 21:20 · Yahoo
Pulmonx Reports Third Quarter 2026 Financial Results
2026-10-27 20:05 · Yahoo
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
2026-10-13 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.